Cargando…
Different stages in drug development for muscle-invasive bladder cancer
Muscle-invasive bladder cancer (MIBC) is a highly aggressive disease. Despite optimal therapy, half of the patients will succumb to disease. This prognosis could not be improved over the last three decades. Therefore, MIBC is left behind from other cancers such as prostate, where novel treatment opt...
Autores principales: | Ineichen, Gallus Beatus, Röthlisberger, Raphael, Johner, Kevin Fabian, Seiler, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760381/ https://www.ncbi.nlm.nih.gov/pubmed/29354493 http://dx.doi.org/10.21037/tau.2017.11.22 |
Ejemplares similares
-
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer
por: Krentel, Friedemann, et al.
Publicado: (2021) -
Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer
por: Jarow, Jonathan, et al.
Publicado: (2015) -
Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial
por: Seiler, Roland, et al.
Publicado: (2023) -
Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture
por: Mi, Haoyang, et al.
Publicado: (2021) -
Neoadjuvant Chemotherapy for Different Stages of Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis
por: Liu, Shuai, et al.
Publicado: (2022)